Whole Coffee Fruit Extract for Exosomal BDNF Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current compositions and methods fail to substantially stimulate brain-derived neurotrophic factor (BDNF) in mammals to a statistically significant degree, and there is a lack of effective means to deliver BDNF across the blood-brain barrier to increase neural tissue levels.
Innovation Solution
Compositions comprising whole coffee fruit extract or procyanidin-enriched preparations, administered orally in small quantities, stimulate BDNF release in exosomal form, effectively increasing blood and cerebral BDNF levels by at least 50% and facilitating delivery across the blood-brain barrier.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional polyphenol or caffeine-rich plant preparations are administered, then BDNF stimulation is attempted, but the increase in BDNF is not statistically significant
Solution Approach 1:
The patent changes the chemical parameters of the administered substance by using procyanidin-enriched preparations with specific concentration ranges (5-95% procyanidins) rather than conventional polyphenol or caffeine-rich preparations. This parameter change in composition enables statistically significant BDNF increase (p<0.05) that was not achieved by prior art substances.
2Quantity of substance
If BDNF delivery across the blood-brain barrier is attempted using conventional methods, then neural tissue BDNF levels are targeted, but effective delivery is not achieved
Solution Approach 1:
The patent uses procyanidin-enriched preparations as an intermediary substance that facilitates BDNF delivery across the blood-brain barrier. These preparations act as a mediator that enables transport of BDNF to neural tissue without requiring complex delivery devices or invasive procedures, achieving effective BDNF levels in the brain through oral administration.
3Quantity of substance
If larger doses of BDNF-stimulating substances are administered, then BDNF levels may increase more, but the complexity and potential side effects increase
Solution Approach 1:
The patent optimizes the dosage parameters by administering procyanidin-enriched preparations at specific concentration ranges (5-95% procyanidins) and dosages (50-500 mg) that achieve effective BDNF levels without requiring excessively large doses. This parameter optimization simplifies the dosage regimen while maintaining effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions significantly elevate exosomal BDNF levels, achieving a 2- to 4-fold increase, particularly enhancing BDNF delivery to the brain and neural tissues, addressing conditions associated with low BDNF levels.
Implementation Method 1
the compositions and methods, when orally administered in relatively small quantities (e.g., between 50-150 mg), stimulate BDNF release in exosomal form, which was demonstrated to be the predominant fraction of the increased BDNF in blood upon administration of contemplated compositions
Data Source
AI summary
Compositions and methods are presented that substantially increase levels of BDNF in blood, and even more pronouncedly exosomal BDNF levels. Suitable compositions include whole coffee fruit extracts and powders that are orally administered at relatively low dosages.